首页> 外文OA文献 >Carboxyl Terminus of Apolipoprotein A-I (ApoA-I) Is Necessary for the Transport of Lipid-free ApoA-I but Not Prelipidated ApoA-I Particles through Aortic Endothelial Cells*
【2h】

Carboxyl Terminus of Apolipoprotein A-I (ApoA-I) Is Necessary for the Transport of Lipid-free ApoA-I but Not Prelipidated ApoA-I Particles through Aortic Endothelial Cells*

机译:载脂蛋白A-I(ApoA-I)的羧基末端对于无脂质ApoA-I而非预先脂质化ApoA-I颗粒通过主动脉内皮细胞的运输是必需的*

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

High density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) must leave the circulation and pass the endothelium to exert their atheroprotective actions in the arterial wall. We previously demonstrated that the transendothelial transport of apoA-I involves ATP-binding cassette transporter (ABC) A1 and re-secretion of lipidated particles. Transendothelial transport of HDL is modulated by ABCG1 and the scavenger receptor BI (SR-BI). We hypothesize that apoA-I transport is started by the ABCA1-mediated generation of a lipidated particle which is then transported by ABCA1-independent pathways. To test this hypothesis we analyzed the endothelial binding and transport properties of initially lipid-free as well as prelipidated apoA-I mutants. Lipid-free apoA-I mutants with a defective carboxyl-terminal domain showed an 80% decreased specific binding and 90% decreased specific transport by aortic endothelial cells. After prior cell-free lipidation of the mutants, the resulting HDL-like particles were transported through endothelial cells by an ABCG1- and SR-BI-dependent process. ApoA-I mutants with deletions of either the amino terminus or both the amino and carboxyl termini showed dramatic increases in nonspecific binding but no specific binding or transport. Prior cell-free lipidation did not rescue these anomalies. Our findings of stringent structure-function relationships underline the specificity of transendothelial apoA-I transport and suggest that lipidation of initially lipid-free apoA-I is necessary but not sufficient for specific transendothelial transport. Our data also support the model of a two-step process for the transendothelial transport of apoA-I in which apoA-I is initially lipidated by ABCA1 and then further processed by ABCA1-independent mechanisms.
机译:高密度脂蛋白(HDL)和载脂蛋白A-I(apoA-I)必须离开循环并通过内皮,以在动脉壁发挥其动脉粥样硬化保护作用。我们以前证明apoA-I的跨内皮运输涉及ATP结合盒转运蛋白(ABC)A1和脂化颗粒的重新分泌。 HDL的跨内皮运输受ABCG1和清除剂受体BI(SR-BI)调节。我们假设apoA-I的运输是由ABCA1介导的脂化颗粒的产生开始的,然后再由ABCA1独立的途径进行运输。为了检验该假设,我们分析了最初无脂质以及预脂化的apoA-I突变体的内皮结合和转运特性。具有缺陷的羧基末端结构域的无脂质apoA-I突变体显示,主动脉内皮细胞的特异性结合降低了80%,特异性转运降低了90%。突变体经过先前的无细胞脂化处理后,通过依赖ABCG1和SR-BI的过程将生成的HDL样颗粒转运通过内皮细胞。具有氨基末端或氨基末端和羧基末端都缺失的ApoA-1突变体显示出非特异性结合的显着增加,但没有特异性结合或转运。先前的无细胞脂化不能挽救这些异常。我们对严格的结构-功能关系的发现强调了跨内皮apoA-I转运的特异性,并表明最初无脂质的apoA-I的脂化对于特定的跨内皮转运是必要的,但还不够。我们的数据也支持apoA-I跨内皮运输的两步过程模型,其中apoA-I最初被ABCA1脂化,然后被ABCA1独立机制进一步处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号